Epstein Barr Virus / EBV EBNA 3B Sheep Polyclonal Antibody

SKU
AP05014PU-N
Epstein Barr Virus / EBV EBNA 3B sheep polyclonal antibody, Purified
  $775.00
5 Days*
Bulk/Customize
Specifications
Specifications
Product Data
Application WB
Recommended Dilution Western Blot: 1-5 µg/ml.
Reactivity Epstein Barr Virus
Antibody Host Sheep
Isotype IgG
Clonality Polyclonal
Immunogen Recombinant EBNA-3B protein.
Specificity This antibody recognizes EBV EBNA 3B.
Buffer PBS
State: Purified
State: Liquid purified Ig (0.2µm sterile filtered)
Preservative: 0.08% Sodium Azide
Concentration lot specific
Purification Ammonium Sulfate Precipitation
Conjugation Unconjugated
Storage Upon receipt, store undiluted (in aliquots) at -20°C.
Avoid repeated freezing and thawing.
Stability Shelf life: one year from despatch.
Shipping Blue Ice
Background EBNA-3B is one of only 10 viral proteins expressed in EBV-transformed B lymphoblasts cultured in vitro, through the expression of EBNA 3B is not required for EBV-mediated transformation in vitro. This 165kDa nuclear protein functions as a transcription factor.
Synonyms HHV4, HHV-4
Reference Data
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma
Anderton, Yee, Smith et al
Oncogene (2008) 27 (4), 421-33 DOI: 10.1038/sj.onc.1210668
Cited by 185
AI Summary: In this study, OriGene’s Bim (BCL2L11) shRNA lentiviral particles were used to knock down Bim expression in Burkitt’s lymphoma cells, enabling the authors to demonstrate that EBV oncoproteins EBNA3A and EBNA3C repress Bim to promote cell survival and drug resistance.
Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter
Jiménez-Ramírez, Brooks, Forshell et al
J Virol (2006) 80 (22), 11200-8 DOI: 10.1128/JVI.00897-06
AI Summary: In this study, OriGene’s EBNA-3C expression plasmid (RC206307) was used to inducibly express EBNA-3C in EBV-positive cell lines, enabling the authors to investigate how EBNA-3C regulates LMP-1 and LMP-2B gene expression from their shared promoter.
Virus and cell RNAs expressed during Epstein-Barr virus replication
Yuan, Cahir-McFarland, Zhao et al
J Virol (2006) 80 (5), 2548-65 DOI: 10.1128/JVI.80.5.2548-2565.2006
AI Summary: OriGene products contributed to this study by providing the BZLF1 (Cat# SC117377) and LMP1 (Cat# SC118040) cDNA clones, which were used to analyze the expression of EBV immediate-early and latency RNAs during virus replication.
Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model
Hong, Gulley, Feng et al
J Virol (2005) 79 (22), 13993-4003 DOI: 10.1128/JVI.79.22.13993-14003.2005
AI Summary: OriGene products, including the human IL-6 ELISA kit (Cat# SEK10361) and the human IL-10 ELISA kit (Cat# SEK10395), were used to quantitatively measure cytokine levels, helping demonstrate that lytic-defective EBV mutants showed reduced IL-6 and IL-10 expression compared to wild-type controls in this study.
EBNA3C coactivation with EBNA2 requires a SUMO homology domain
Rosendorff, Illanes, David et al
J Virol (2004) 78 (1), 367-77 DOI: 10.1128/jvi.78.1.367-377.2004
Cited by 58
AI Summary: In this paper, OriGene’s anti-EBNA3C antibody (TA806166) was used to detect EBNA3C protein expression, contributing to the characterization of EBNA3C’s interaction with SUMO proteins and its role in EBNA2-mediated gene activation.
Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2
O'Nions, Allday
Oncogene (2003) 22 (46), 7181-91 DOI: 10.1038/sj.onc.1206838
Cited by 29
AI Summary: OriGene products, specifically the anti-p21 (TA300143) and anti-cyclin D2 (TA500127) antibodies, were used in this study to detect the levels of p21 and cyclin D2 proteins, helping to demonstrate how EBV infection prevents their normal regulation following genotoxic stress.
Showing 1-6 of 8 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products